Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence

9 Dec 2014

Abstract excerpt

OBJECTIVE: To better characterize the genomics of patients with biochemical recurrence (BCR) who have metastatic disease progression in order to improve treatment decisions for prostate cancer. METHODS: The expression profiles of three clinical outcome groups after radical prostatectomy (RP) were compared: those with no evidence of disease (NED; n = 108); those with BCR (rise in prostate-specific antigen [PSA]...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mechanisms of cancer metastasis
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25762434
DOI: 10.1111/bju.13013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrencePMID 25762434Read ↗

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.Semantic proximity Read ↗

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read ↗

Gene expression profiling predicts clinical outcome of prostate cancerSemantic proximity Read ↗

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read ↗

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.Semantic proximity Read ↗

Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.Semantic proximity Read ↗

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐CSemantic proximity Read ↗

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumorSemantic proximity Read ↗

Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.Semantic proximity Read ↗

Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.Semantic proximity Read ↗

Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processSemantic proximity Read ↗

Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.